Cervical Cancer

Drugs for Cervical Cancer

Here are the financial support services available to patients receiving treatment for Cervical Cancer.

Avastin (bevacizumab)

Drug company: Genentech

Avastin is a VEGF-specific angiogenesis inhibitor used, in combination with paclitaxel and cisplatin or paclitaxel and topotecan, for the treatment of patients with persistent, recurrent, or metastatic cervical cancer.

Genentech offers 2 financial assistance programs for patients using Avastin:

Genentech BioOncology Co-pay Card

Patients with private insurance pay a $25 copay, and up to $25,000 is paid by the program annually; there are no income requirements for participation.

Genentech Access to Care Foundation

This foundation provides Avastin free of charge to uninsured or underinsured patients whose household income is less than $100,000 or for patients whose annual household in­come is less than $150,000 and their out-of-pocket prescription costs exceed 5% of their income (regardless of insurance).

Hycamtin (topotecan hydrochloride injection)

Drug company: Novartis

Hycamtin for injection is a topoisomerase inhibitor used, in combination with cisplatin, for the treatment of patients with stage IV-B, recurrent or persistent carcinoma of the cervix.

Novartis’ Patient Assistance NOW Oncology offers 1 financial assistance program for patients using Hycamtin:

Novartis Patient Assistance Foundation

Patients who are experiencing financial hardship and have limited or no public or private prescription coverage may be able to receive Hycamtin for free through the Novartis Patient Assistance Foundation. To be eligible, the patient must be a US citizen, and have an annual household income of up to $75,000 for 1 person; $100,000 for 2 people; $125,000 for 3 people; $150,000 for 4 people; and up to $25,000 more for each additional person in the household. Eligible patients will receive Hycamtin for free for 1 year, or until prescription drug coverage becomes available to them.

Table. Drugs Prescribed for Cervical Cancer

  • Drug name (generic name)
  • Drug company
  • Indication
  • Patient support services
    Drug name (generic name)
  • Hycamtin (topotecan hydrochloride injection)
  • Drug company
  • Novartis
  • Indication
  • Stage IV-B, recurrent or persistent carcinoma of the cervix, in combination with cisplatin
  • Patient support services
  • Novartis Patient Assistance Foundation

Last modified: April 16, 2018

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.